Literature DB >> 1914141

Regional cerebral blood flow during hypoxia-ischemia in the immature rat: comparison of iodoantipyrine and iodoamphetamine as radioactive tracers.

M Ringel1, R M Bryan, R C Vannucci.   

Abstract

The indicator fractionation method was used to measure regional cerebral blood flow (rCBF) in immature rats, using either iodo-[14C]antipyrine (IAP) or isopropyl-[14C]iodoamphetamine (IPIA) as the radioisotope. Seven-day postnatal rats received a subcutaneous injection of either IAP (5 microCi) of IPIA (10 microCi), two minutes following which the animals were sacrificed and their brains prepared for quantitative autoradiography. Blood flows to cerebral cortex, hippocampus, striatum, thalamus and hypothalamus were comparable using the two methods, whereas blood flows to white matter structures were substantially higher (+ 64-85%) with IAP. Spatial resolution, especially of the gray matter structures, was greater with IPIA than with IAP. During cerebral hypoxia-ischemia (unilateral common carotid artery ligation and hypoxia with 8% oxygen), blood flows to all regions of the ipsilateral cerebral hemisphere were not different from control at 10 and 20 min. At 1-3 h of hypoxia-ischemia, blood flows were decreased in all analyzed structures of the cerebral hemisphere ipsilateral to the carotid artery occlusion, ranging from 7% to 40% of control values. A columnar or patchy distribution of preferential perfusion was seen within the cerebral cortex, striatum and thalamus, with IPIA, which corresponds closely to the pathologic pattern of injury seen within these structures of the immature rat. Such a preferential perfusion was not seen in hippocampus, in which metabolic factors (intrinsic vulnerability) most likely predict the distribution of hypoxic-ischemic brain damage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1914141     DOI: 10.1016/0165-3806(91)90103-p

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  8 in total

1.  Dynamic spatio-temporal imaging of early reflow in a neonatal rat stroke model.

Authors:  Pierre-Louis Leger; Philippe Bonnin; Pierre Lacombe; Elisabeth Couture-Lepetit; Sebastien Fau; Sylvain Renolleau; Abdallah Gharib; Olivier Baud; Christiane Charriaut-Marlangue
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-10       Impact factor: 6.200

Review 2.  Chronic toxicity of environmental contaminants: sentinels and biomarkers.

Authors:  G A LeBlanc; L J Bain
Journal:  Environ Health Perspect       Date:  1997-02       Impact factor: 9.031

Review 3.  Invertebrates in testing of environmental chemicals: are they alternatives?

Authors:  L Lagadic; T Caquet
Journal:  Environ Health Perspect       Date:  1998-04       Impact factor: 9.031

4.  Perivascular nitric oxide and superoxide in neonatal cerebral hypoxia-ischemia.

Authors:  Roderic H Fabian; J Regino Perez-Polo; Thomas A Kent
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-01       Impact factor: 4.733

5.  Temporal evolution of neuropathologic changes in an immature rat model of cerebral hypoxia: a light microscopic study.

Authors:  J Towfighi; N Zec; J Yager; C Housman; R C Vannucci
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

6.  Unilateral blood flow decrease induces bilateral and symmetric responses in the immature brain.

Authors:  Sonia Villapol; Philippe Bonnin; Sébastien Fau; Olivier Baud; Sylvain Renolleau; Christiane Charriaut-Marlangue
Journal:  Am J Pathol       Date:  2009-10-08       Impact factor: 4.307

7.  Are environmental sentinels signaling?

Authors:  G A LeBlanc
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

8.  Brain barrier properties and cerebral blood flow in neonatal mice exposed to cerebral hypoxia-ischemia.

Authors:  C Joakim Ek; Barbara D'Angelo; Ana A Baburamani; Christine Lehner; Anna-Lena Leverin; Peter L P Smith; Holger Nilsson; Pernilla Svedin; Henrik Hagberg; Carina Mallard
Journal:  J Cereb Blood Flow Metab       Date:  2015-01-28       Impact factor: 6.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.